Herpes simplex virus infections: New treatment approaches make early diagnosis even more important

Postgraduate Medicine

Volumn 107, Issue 3, 2000, Pages 189-200

  Nadelman, Celina M ^a   Newcomer, Victor D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CIDOFOVIR; DNA POLYMERASE; FAMCICLOVIR; FOSCARNET SODIUM; GANCICLOVIR; PENCICLOVIR; THYMIDINE KINASE; TRIFLURIDINE; VALACICLOVIR;

ARTICLE; EARLY DIAGNOSIS; GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOFLUORESCENCE; KERATOCONJUNCTIVITIS; NEWBORN INFECTION; PATIENT EDUCATION; QUALITY OF LIFE; RECURRENT INFECTION; SEXUALLY TRANSMITTED DISEASE; SKIN BIOPSY; UNITED STATES; VIRUS CULTURE; VIRUS ENCEPHALITIS; VIRUS TRANSMISSION;

EID: 0034104762     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2000.03.948     Document Type: Article

References (17)

1. Brown Z, Dudley M, Habif T, et al. Audio forum on herpes simplex virus: patient counseling. Scientific Exchange Inc, Nov 1996
2. Brown Z, Patel R, Reitano M, et al. Hcrpesvirus infections: treatment options in the new millennium. A symposium report. World Health CME, World Health Communications, Inc, Denver, April 29, 1996
3. Brown Z, Dudley M, Habif T, et al. Audio forum on herpes simplex virus: suppressive therapy. Scientific Exchange Inc, Sep 1996
4. Fleming D, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337(16):1105-11
5. Habif T. The diagnostic manual of herpesvirus infections. Research Triangle Park, NC: Burroughs Wellcome Co, 1995
6. Fitzpatrick TB, et al. Dermatology in general medicine. 4th ed. New York: McGraw-Hill, 1993:2531-47
7. Spruance SL, Rea TL, Thoming C, et al. Penciclovir cream for the treatment of herpes simplex labialis: a randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group. JAMA 1997; 277(17):1373-9
8. Bodsworth NJ, Crooks RJ, Borelli S, et al. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Vaiaciclovir HSV Study Group. Genitourin Med 1997; 73(2):110-6
9. Habif TB. Clinical dermatology. 3d ed. Mosby-Year Book, 1996:306-13, 337-44
10. Goldberg LH, Kaufman R, Kurtz TO, et al. Long-term suppression of recurrent genital herpes with acyclovir: a 5-year benchmark acyclovir study group. Arch Dermatol 1993;129(5):582-7
11. McCrary ML, Memar OM, Herne KB, et al. Drugs with antiviral activity used in clinical dermatology. Fitzpatrick's J Clin Dermatol 1995;3(6):44-51
12. Drugs for non-HIV viral infections. Med Lett Drug Ther 1997;39(1006):69-76
13. Wald A. Beyond efficacy: new issues for HSV antiviral therapy. Genitourin Med 1997;73(2):83-4
14. PCS Rx Review. New trends in prescription therapies, benefits, costs: current antiviral therapies for herpes virus. Scottsdale, AZ: PCS Health Systems, Spring 1997
15. Valtrex caplets: occurrence of thrombotic microangiopathy (TMA) in severely immunocompromised patients [physician handout]. Research Triangle Park, NC: Glaxo Wellcome, 1996
16. Valtrex caplets: use for the suppression of recurrent genital herpes infections [physician handout]. Research Triangle Park, NC: Glaxo Wellcome, 1996
17. Topical penciclovir for herpes labialis. Med Lett Drug Ther 1997;39(1003):57-9